Menu
GeneBe

rs2230054

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001557.4(CXCR2):c.786C>T(p.Leu262=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.489 in 1,613,788 control chromosomes in the GnomAD database, including 196,054 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 22382 hom., cov: 31)
Exomes 𝑓: 0.48 ( 173672 hom. )

Consequence

CXCR2
NM_001557.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.953
Variant links:
Genes affected
CXCR2 (HGNC:6027): (C-X-C motif chemokine receptor 2) The protein encoded by this gene is a member of the G-protein-coupled receptor family. This protein is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein activated second messenger system. This receptor also binds to chemokine (C-X-C motif) ligand 1 (CXCL1/MGSA), a protein with melanoma growth stimulating activity, and has been shown to be a major component required for serum-dependent melanoma cell growth. This receptor mediates neutrophil migration to sites of inflammation. The angiogenic effects of IL8 in intestinal microvascular endothelial cells are found to be mediated by this receptor. Knockout studies in mice suggested that this receptor controls the positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. This gene, IL8RA, a gene encoding another high affinity IL8 receptor, as well as IL8RBP, a pseudogene of IL8RB, form a gene cluster in a region mapped to chromosome 2q33-q36. Alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 2-218135587-C-T is Benign according to our data. Variant chr2-218135587-C-T is described in ClinVar as [Benign]. Clinvar id is 1164812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.953 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.659 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CXCR2NM_001557.4 linkuse as main transcriptc.786C>T p.Leu262= synonymous_variant 3/3 ENST00000318507.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CXCR2ENST00000318507.7 linkuse as main transcriptc.786C>T p.Leu262= synonymous_variant 3/31 NM_001557.4 P1

Frequencies

GnomAD3 genomes
AF:
0.533
AC:
80960
AN:
151824
Hom.:
22350
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.666
Gnomad AMI
AF:
0.688
Gnomad AMR
AF:
0.524
Gnomad ASJ
AF:
0.574
Gnomad EAS
AF:
0.326
Gnomad SAS
AF:
0.498
Gnomad FIN
AF:
0.398
Gnomad MID
AF:
0.684
Gnomad NFE
AF:
0.488
Gnomad OTH
AF:
0.564
GnomAD3 exomes
AF:
0.483
AC:
121474
AN:
251420
Hom.:
30041
AF XY:
0.485
AC XY:
65836
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.666
Gnomad AMR exome
AF:
0.470
Gnomad ASJ exome
AF:
0.561
Gnomad EAS exome
AF:
0.326
Gnomad SAS exome
AF:
0.486
Gnomad FIN exome
AF:
0.406
Gnomad NFE exome
AF:
0.491
Gnomad OTH exome
AF:
0.518
GnomAD4 exome
AF:
0.484
AC:
707995
AN:
1461846
Hom.:
173672
Cov.:
95
AF XY:
0.485
AC XY:
352516
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.675
Gnomad4 AMR exome
AF:
0.480
Gnomad4 ASJ exome
AF:
0.566
Gnomad4 EAS exome
AF:
0.317
Gnomad4 SAS exome
AF:
0.485
Gnomad4 FIN exome
AF:
0.403
Gnomad4 NFE exome
AF:
0.485
Gnomad4 OTH exome
AF:
0.507
GnomAD4 genome
AF:
0.533
AC:
81019
AN:
151942
Hom.:
22382
Cov.:
31
AF XY:
0.528
AC XY:
39206
AN XY:
74240
show subpopulations
Gnomad4 AFR
AF:
0.665
Gnomad4 AMR
AF:
0.523
Gnomad4 ASJ
AF:
0.574
Gnomad4 EAS
AF:
0.326
Gnomad4 SAS
AF:
0.499
Gnomad4 FIN
AF:
0.398
Gnomad4 NFE
AF:
0.488
Gnomad4 OTH
AF:
0.564
Alfa
AF:
0.520
Hom.:
9002
Bravo
AF:
0.546
EpiCase
AF:
0.494
EpiControl
AF:
0.511

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 10, 2018- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 75% of patients studied by a panel of primary immunodeficiencies. Number of patients: 71. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
Cadd
Benign
2.1
Dann
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230054; hg19: chr2-219000310; COSMIC: COSV59280021; COSMIC: COSV59280021; API